The Finnish Medicines Agency (Fimea) would like to thank the European Commission for the possibility to comment on the Proposal for a Regulation of the European Parliament and of the Council on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC (hereafter, the SoHO Regulation Proposal).
FMA
Finnish Medicines Agency
Public authority · Finland
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
2
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track Finnish in PolicySpeak: request access →
Work at Finnish Medicines Agency? so we know who speaks for it.
Their record over time
Finnish Medicines Agency filed 2 positions between 7 Sept 2022 and 6 Jun 2023, across 2 of the 583 legislative files tracked here, attaching a full position paper 1 time.
2022 · 1 filed2023 · 1 filed
What they argued
The proposal to strenghten the regulations in the issue of designer precursors is considered important. Therefore the policy options 3 and 4 are the ones which could result in such strengthening. There still is room however for innovation in how perhaps modify the regulations for industry and users concerning specifically and only the substances without known legitimate uses and therefore leaving the regulations…
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Finnish Medicines Agency next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Is this your organization?
Everything on this page comes from Finnish Medicines Agency’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.